Literature DB >> 6650766

Diuresis with continuous infusion of furosemide after cardiac surgery.

J G Copeland, D W Campbell, J R Plachetka, N W Salomon, D F Larson.   

Abstract

We prospectively evaluated the diuretic effect of furosemide administered by bolus injection and by continuous infusion in 18 cardiac surgery patients. Nine patients were randomly assigned to receive 0.3 mg/kg of furosemide as a bolus injection at time 0 and again 6 hours later (nine patients) or 0.05 mg/kg per hour of furosemide as a constant infusion for 12 hours (nine patients). There were no significant differences between groups with respect to age, weight, creatinine clearance, changes in serum sodium and potassium levels, total urinary concentrations of sodium and potassium, or total urine volume for 12 hours. Diuresis during continuous infusion of furosemide was less variable from hour to hour than after bolus injection of furosemide and was sustained throughout the infusion period. Although the continuous infusion of furosemide will not provide the rapid and vigorous diuresis that is necessary in some clinical situations, it may be useful whenever a gentle, sustained diuresis is desired.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6650766     DOI: 10.1016/0002-9610(83)90344-6

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  19 in total

1.  Continuous versus intermittent administration of furosemide in acute decompensated heart failure: a systematic review and meta-analysis.

Authors:  Akira Kuriyama; Seigo Urushidani
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

Review 2.  Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships.

Authors:  D A Sica; T W Gehr
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

3.  Supraventricular tachycardia associated with continuous furosemide infusion.

Authors:  N J Wilson; R J Adderley; J A McEniery
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

Review 4.  The efficiency concept in pharmacodynamics.

Authors:  G Alván; G Paintaud; M Wakelkamp
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

5.  Diuretic strategies in patients with acute decompensated heart failure.

Authors:  G Michael Felker; Kerry L Lee; David A Bull; Margaret M Redfield; Lynne W Stevenson; Steven R Goldsmith; Martin M LeWinter; Anita Deswal; Jean L Rouleau; Elizabeth O Ofili; Kevin J Anstrom; Adrian F Hernandez; Steven E McNulty; Eric J Velazquez; Abdallah G Kfoury; Horng H Chen; Michael M Givertz; Marc J Semigran; Bradley A Bart; Alice M Mascette; Eugene Braunwald; Christopher M O'Connor
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

6.  Intermittent administration of furosemide or continuous infusion in critically ill infants and children: does it make a difference?

Authors:  J Klinge
Journal:  Intensive Care Med       Date:  2001-04       Impact factor: 17.440

7.  Heart failure: furosemide--to DOSE or not to DOSE, that is the question.

Authors:  Lisa C Costello-Boerrigter; John C Burnett
Journal:  Nat Rev Cardiol       Date:  2011-05-31       Impact factor: 32.419

8.  Comparison of three diuretic treatment strategies for patients with acute decompensated heart failure.

Authors:  Çağrı Yayla; Ahmet Akyel; Uğur Canpolat; Kadriye Gayretli Yayla; Azmi Eyiol; Mehmet Kadri Akboğa; Sedat Türkoğlu; Yusuf Tavil; Bülent Boyacı; Atiye Çengel
Journal:  Herz       Date:  2015-07-02       Impact factor: 1.443

9.  Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous furosemide.

Authors:  T Li; M G Lee; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1986-10

Review 10.  Loop diuretics in acute decompensated heart failure: necessary? Evil? A necessary evil?

Authors:  G Michael Felker; Christopher M O'Connor; Eugene Braunwald
Journal:  Circ Heart Fail       Date:  2009-01       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.